Showing results (131-140 of 199) with videos related to
Sort By:
Pageof 20
Blood|October 7, 2000
Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapyG V Matthews, M Bower, S Mandalia, et al.Alimentary Pharmacology & Therapeutics|November 19, 2010
Increased proportion of CD16(+) NK cells in the colonic lamina propria of inflammatory bowel disease patients, but not after azathioprine treatmentA W Steel, C M Mela, J O Lindsay, et al.The Journal of Infectious Diseases|September 9, 1999
Chemokine receptor polymorphisms and human immunodeficiency virus disease progressionP J Easterbrook, T Rostron, N Ives, et al.AIDS (London, England)|August 1, 1994
Reversible renal failure caused by a microsporidian infectionE J Aarons, D Woodrow, W S Hollister, et al.The Journal of Infection|March 1, 1988
Disseminated Mycobacterium avium-intracellulare infection and red cell hypoplasia in patients with the acquired immune deficiency syndromeT D Gardener, P Flanagan, M S Dryden, et al.AIDS (London, England)|February 1, 1997
Long-term survival in patients with advanced immunodeficiencyG Chêne, P J Easterbrook, E Juszczak, et al.Clinical and Experimental Immunology|October 20, 2005
Immunological and virological consequences of patient-directed antiretroviral therapy interruption during chronic HIV-1 infectionC T Burton, M R Nelson, P Hay, et al.European Journal of Cancer (Oxford, England : 1990)|September 24, 1999
Treatment outcome in presumed and confirmed AIDS-related primary cerebral lymphomaM Bower, K Fife, A Sullivan, et al.Genitourinary Medicine|August 1, 1996
Pneumothorax in AIDS: case reviews and proposed clinical managementD Asboe, M Fisher, M R Nelson, et al.The British Journal of Ophthalmology|May 26, 1999
Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective studyS M Mitchell, W L Membrey, M S Youle, et al.Pageof 20